Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Clients report that they feel motivated knowing experts are watching their progress
The evidence is modest
At a glance Target population / adult women aged 18+, BMI 30 or BMI 27 with comorbidity Primary medications / semaglutide (Wegovy/Ozempic-class) and tirzepatide (Zepbound/Mounjaro-class) Business model / cash-pay telehealth
Paradies G, Paradies V, Ruggiero FM, Petrosillo G (2014) Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease
While the SAFE Drugs Act remains under legislative consideration, the FDA and state attorneys general appear to already be implementing more aggressive oversight measures until a more stringent oversight framework is in place
US$ 27.38
US$ 21.30
US$ 29.62
